Analysis and Perception of Chlamydia psittaci Pneumonia: Novel Insights of the Rare Disease in Infectiology
He Huang,Yanquan Liu,Yuan Liu,Jie Lin,Huidong Guo,Qinglin Xu,Hehui Zhang,Zuotao Li,Hongquan Zhu,Mingli Ding
DOI: https://doi.org/10.2147/idr.s486895
2024-11-28
Infection and Drug Resistance
Abstract:He Huang, 1, &ast Yanquan Liu, 2, &ast Yuan Liu, 1, &ast Jie Lin, 3 Huidong Guo, 4 Qinglin Xu, 3 Hehui Zhang, 3 Zuotao Li, 3 Hongquan Zhu, 3 Mingli Ding 5 1 The First Affiliated Hospital (The First School of Clinical Medicine) of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China; 2 The First School of Clinical Medicine, Guangdong Medical University, Dongguan, Guangdong, People's Republic of China; 3 Department of Intensive Medicine (Comprehensive ICU), The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China; 4 Department of Pathology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China; 5 Department of Nosocomial Infection Management, Ganzhou People's Hospital, Ganzhou, Jiangxi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Mingli Ding, Department of Nosocomial Infection Management, Ganzhou People's Hospital, No. 16 Meiguan Avenue, Zhanggong District, Ganzhou, Jiangxi, 341000, People's Republic of China, Email Objective: To investigate and analyze the clinical features, diagnosis and treatment, and prognosis of rare Chlamydia psittaci pneumonia, and to improve the understanding of this rare disease. Methods: A retrospective analysis and exploration was performed for 33 cases of patients with Chlamydia psittaci pneumonia in the First Affiliated Hospital of Gannan Medical University from January 2017 to March 2024, and the clinical features, diagnosis, treatment and key points for differential diagnosis were summarized and analyzed. Meanwhile, the latest literature from PubMed was retrieved to systematically discuss the research progress in Chlamydia psittaci pneumonia. Results: A total of 33 patients with Chlamydia psittaci pneumonia were included in this study, including 21 males (63.64%) and 12 females (36.36%), with a median age of 59 (32– 79) years. There were 27 cases (81.82%) of patients accompanied with a history of poultry contact, 22 patients (66.67%) had underlying diseases. In our study, patients with Chlamydia psittaci pneumonia were mainly affected in Autumn (21.21%) and Winter (54.55%). All patients had undergone bronchoscopy and obtained bronchoalverolar lavage fluid (BALF) for metagenomic next-generation sequencing (mNGS) detection, and mNGS results showed that all patients (100%) were co-infected with multiple pathogens including Chlamydia psittaci . All patients were given antimicrobial therapy after diagnosis, and no treatment-related adverse reactions or adverse events were observed in our study, the average length of hospitalization was 11.09 days. Fortunately, no death was observed in our study, and patients were all discharged from hospital after recovery and in favourable physical and psychological conditions after discharge. Conclusion: Chlamydia psittaci pneumonia lacks specific clinical features or manifestations and tends to develop into severe exacerbation. mNGS could help to achieve an accurate diagnosis. Early administration of antibiotics can improve the prognosis of patients to the greatest extent. Keywords: Chlamydia psittaci pneumonia, clinical features, diagnosis, differential diagnosis, precise treatment, mNGS, evidence-based medicine, prognosis Community-acquired pneumonia (CAP) is one of the most commonly treated diseases in the respiratory department and intensive care unit (ICU), while Chlamydia psittaci pneumonia is a clinically rare zoonotic disease caused by Chlamydia psittaci infection and also a zoonotic infectious disease, accounting for about 1% of CAP. 1–3 It can occur when exposed to contaminated faeces and nasal secretions from infected birds or poultry, resulting in widespread infection in humans and animals, posing significant socio-economic and public health security challenges, and is a truly notorious rare subtype of CAP. Patients with mild Chlamydia psittaci pneumonia may have no clinical manifestations or symptoms, while those with severe cases may have severe pneumonia, multiple organ failure, and even death. 4,5 Early diagnosis of Chlamydia psittaci infection is one of the keys to clinical diagnosis, treatment and prevention, and accurate detection results play an indispensable role in controlling disease progression, improving patient prognosis and reducing mortality. 6 However, the clinical manifestations of Chlamydia psittaci pneumonia are mainly -Abstract Truncated-
pharmacology & pharmacy,infectious diseases